Alpine Global Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Alpine Global Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,000	Closed	-$42K	–	337
2021 Q1	$42K	Hold	51,000	–	–	﹤0.01%	294
2020 Q4	$74K	Hold	51,000	–	–	0.02%	181
2020 Q3	$63K	Hold	51,000	–	–	0.01%	208
2020 Q2	$51K	Hold	51,000	–	–	0.01%	309
2020 Q1	$33K	Buy	+51,000	New	+$40.1K	0.01%	190

Other funds holding JSPRW

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

Alpine Global Management's JSPRW Position: Q2 2021 in Review

Alpine Global Management sold out of Japer Therapeutics Warrants (JSPRW) in Q2 2021, closing a stake of 51,000 shares — an estimated $42K sold.

Alpine Global Management first reported a position in JSPRW in Q1 2020 and held it in 5 quarters. The position peaked at $74K in Q4 2020. 20 funds tracked by Wall St. Rank hold JSPRW as of Q2 2021.

Alpine Global Management reported no remaining Japer Therapeutics Warrants position as of Q2 2021 after selling out during the quarter.
Alpine Global Management sold 51,000 Japer Therapeutics Warrants shares in Q2 2021, an estimated $42K.
Alpine Global Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 5 quarters.
Alpine Global Management's Japer Therapeutics Warrants position peaked at $74K in Q4 2020.
20 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2021.

Based on Alpine Global Management's 13F filing for Q2 2021, filed 13 Aug 2021.